Heparine Injection BP 5,000 Units/ml Solution For Injection Kenya - English - Pharmacy and Poisons Board

heparine injection bp 5,000 units/ml solution for injection

rotexmedica gmbh arzneimittelwerk bunsenstrasse 4, 22946 trittau, germany - heparine sodium - solution for injection - 5,000 units heparine sodium per ml - antithrombotic agents: heparin group

CAL-HEPARINE 20000 I.U./0.8ml amp. Egypt - English - EDA (Egyptian Drug Authority)

cal-heparine 20000 i.u./0.8ml amp.

amoun pharmaceutical industries co. - injection - 20000 i.u.

CAL-HEPARINE 12000I.u.amp. Egypt - English - EDA (Egyptian Drug Authority)

cal-heparine 12000i.u.amp.

amoun pharmaceutical industries co. - injection - 12000 i.u.

CAL-HEPARINE 5000I.u. amp. Egypt - English - EDA (Egyptian Drug Authority)

cal-heparine 5000i.u. amp.

amoun pharmaceutical industries co. - injection - 5000 i.u.

Heparine Leo 5000 IU/ml inj./inf. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

heparine leo 5000 iu/ml inj./inf. sol. i.v. vial

leo pharma sa-nv - heparin sodium 5000 iu/ml - solution for injection/infusion - 5000 iu/ml - heparin sodium 5000 iu/ml - heparin

Heparine Leo 100 IU/ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

heparine leo 100 iu/ml inj. sol. i.v. vial

leo pharma sa-nv - heparin sodium 100 iu/ml - solution for injection - 100 iu/ml - heparin sodium 100 iu/ml - heparin

Heparine Natrium B. Braun 25000 IU/5 ml inj. sol. i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

heparine natrium b. braun 25000 iu/5 ml inj. sol. i.v. vial

b. braun melsungen ag - heparin sodium 25000 iu/5 ml - solution for injection - 25000 iu/5 ml - heparin sodium 25000 iu - heparin

Thorinane European Union - English - EMA (European Medicines Agency)

thorinane

pharmathen s.a. - enoxaparin sodium - venous thromboembolism - antithrombotic agents - thorinane is indicated for adults for: - prophylaxis of venous thromboembolism, particularly in patients undergoing orthopaedic, general or oncological surgery. - prophylaxis of venous thromboembolism in patients bedridden due to acute illnesses including acute heart failure, acute respiratory failure, severe infections, as well as exacerbation of rheumatic diseases causing immobilisation of the patient (applies to strengths of 40 mg/0.4 ml). - treatment of deep vein thrombosis (dvt), complicated or uncomplicated by pulmonary embolism. - treatment of unstable angina and non q wave myocardial infarction, in combination with acetylsalicylic acid (asa). - treatment of acute st segment elevation myocardial infarction (stemi) including patients who will be treated conservatively or who will later undergo percutaneous coronary angioplasty (applies to strengths of 60 mg/0.6 ml, 80 mg/0.8 ml, and 100 mg/1 ml). - blood clot prevention in the extracorporeal circulation during haemodialysis. prevention and treatment of various disorders related to blood clots in adults.,